Kiora Pharmaceuticals, Inc., was incorporated as a Delaware corporation on December 26, 2004 under the name EyeGate Pharmaceuticals, Inc., and changed its name to Kiora Pharmaceuticals, Inc., effective November 8, 2021. The Company is a clinical stage specialty pharmaceutical company focused on the development and commercialization of therapies and drug delivery for the treatment of eye diseases. 

Kiora Pharmaceuticals shares rise 10.14% intraday on technical breakout and short-covering surge.

Kiora Pharmaceuticals shares surge 31.25% intraday on technical breakout and short squeeze.

Kiora Pharmaceuticals shares rise 11.11% intraday after closing $5M private placement with $19M warrant upside.

Kiora Pharmaceuticals

Kiora Pharmaceuticals Secures $24 Million Private Placement Led by Perceptive Advisors

Kiora Pharmaceuticals shares surge 21.80% intraday after securing up to $24M private placement and entering securities purchase agreement with Perceptive Advisors and ADAR1 Capital.

KPRX News